checkAd
    Startseite > Aktien > AlzeCure Pharma > Nachrichten
    AlzeCure Pharma Aktie
    0,1500
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 31.05.24 Frankfurt
    0,1640
     
    EUR
    12.200 STK
    Geldkurs 31.05.24
    0,2190
     
    EUR
    13.700 STK
    Briefkurs 31.05.24
    ISIN: SE0010133785 · WKN: A2N951 · SYM: AC6 · Schweden

    Neueste Nachrichten

    Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
    15.05.24 · Accesswire · AlzeCure Pharma
    Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2024
    14.05.24 · Accesswire · AlzeCure Pharma
    AlzeCure Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer's Leading to New Patent Application
    13.05.24 · Accesswire · AlzeCure Pharma
    AlzeCure Publishes its Interim Report for January - March 2024
    25.04.24 · Accesswire · AlzeCure Pharma
    Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board
    10.04.24 · Accesswire · AlzeCure Pharma
    AlzeCure Pharma Publishes its Annual Report for 2023
    04.04.24 · Accesswire · AlzeCure Pharma
    AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024
    03.04.24 · Accesswire · AlzeCure Pharma
    AlzeCure to Partake in Redeye Theme: Alzheimer on March 21
    14.03.24 · Accesswire · AlzeCure Pharma
    AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at Leading Alzheimer's Conference
    07.03.24 · Accesswire · AlzeCure Pharma
    AlzeCure Publishes Clinical Results Supporting Continued Development of NeuroRestore ACD856 Against Alzheimer's
    05.03.24 · Accesswire · AlzeCure Pharma
    AlzeCure's Alzheimer's Project NeuroRestore ACD856 is Granted an Additional Patent
    29.02.24 · Accesswire · AlzeCure Pharma
    AlzeCure Publishes its Year-end Report for January - December 2023
    27.02.24 · Accesswire · AlzeCure Pharma